Seeger Weiss Blog
Seeger Weiss Blog: Legal News and Analysis

Archives : 2012 : May

Christopher A. Seeger Named Plaintiffs’ Co-Lead Counsel in Multidistrict NFL Concussion Litigation

May 15th, 2012

Seeger Weiss is pleased to announce that founding partner Christopher A. Seeger has recently been appointed as Plaintiffs’ Co-Lead Counsel in the litigation pending in the Eastern District of Pennsylvania. The litigation, styled as In Re: National Football League Players’ Concussion Injury Litigation, MDL No. 2323, is pending before the Honorable Anita B. Brody. This appointment comes as thousands of former football players have filed suit against the National Football League  focusing on the negligence of the NFL in not providing adequate warnings of the risks associated with concussions and related head trauma injuries.

In making the appointment during the initial MDL status conference, Judge Brody stated, “I want lead counsel.  I have done my homework on that too.  And I would very much like one of co-lead counsel to be Mr. Seeger, Chris Seeger.  I have to tell you, the ratings of people who have had MDLs with you involved have been very, very high, your law firm.”

If you or someone you know has had a sports related injury, contact us today. An experienced attorney with Seeger Weiss LLP will assist you in evaluating your claim. Attorney consultations incur no obligation on your part and all initial consultations are free of charge. Seeger Weiss LLP has office locations in New York, New Jersey, Philadelphia and California.

FDA Delays Decision on Actos Replacement

May 3rd, 2012

Last week, Japan-based Takeda Pharmaceutical Co Ltd, makers of the drug Actos, announced that the FDA will extend its review of the company’s drug alogliptin. Alogliptin, a diabetes medication, was expected to be the successor to Takeda’s top-selling drug Actos. Before Takeda lost its patent protection on Actos, the type-2 diabetes treatment had been linked to an increased risk of bladder cancer in studies. In response, the FDA issued a warning to doctors who prescribed Actos to patients.

Seeger Weiss LLP, a national plaintiffs’ law firm, has been actively investigating the link between Actos and bladder cancer. If you believe you or someone you know developed bladder cancer as a result of taking Actos, the firm’s drug injury practice will review your case for free. Contact them here.